Delivery Order SPE2DB20D3103-SPE2DB22FN5P0
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Tobradex eye ointment. The $3,430.52 firm-fixed-price contract has a performance period ending on March 30, 2022. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $2,767.50 Firm Fixed Price Delivery Order is for the supply of 4564657159 - Tobradex Eye Ointment 3.5 grams. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,290.35 firm fixed price delivery order is for the supply of 4564097841 Tobradex Eye Ointment 3.5GM to support military treatment programs and facilities. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,546.20 firm-fixed-price contract is for the supply of Tobradex Eye Ointment, a prescription ophthalmic medication. The contract has a completion date of May 14, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Tobradex Eye Ointment 3.5 grams to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., both of which are for-profit organizations. The contract is a Delivery Order with a Firm Fixed Price valued at $5,687.92 and has an ultimate completion date of February 27, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,918.75, is for the delivery of TOBRADEX Eye Ointment 3.5GM, a pharmaceutical product, and was not designated with a set-aside requirement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TOBRADEX eye ointment. The order is valued at $6,353.15 and has a firm fixed price. The contract has an ultimate completion date of August 27, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This is a Delivery Order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of TOBREX 0.3% eye ointment, a pharmaceutical product, with a ceiling value of $1,103.21 and a completion date of February 4, 2025. The contract is Firm Fixed Price and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- The Defense Logistics Agency awarded a $12,048.20 delivery order to AmerisourceBergen Drug Corp for Tobradex eye ointment (3.5 grams) on September 22, 2025, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- This federal contract award, with ID SPE2DX15D6044|SPE2DX23FCRLG, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,141.03 firm fixed-price delivery order is for the supply of Tobrex 0.3% eye ointment, a critical medical product. The contract has an ultimate completion date of May 22, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN5P0Delivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobradex eye ointment. The $11,700.44 firm-fixed-price contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a parent company that also does business as Amerisourcebergen. Cencora, Inc. holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These contract awards demonstrate Amerisourcebergen's role as a critical supplier of essential pharmaceutical and medical products to various federal government agencies, particularly the Department of Defense and its military treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 5/5/22 |